Add like
Add dislike
Add to saved papers

Photo-catalytic Killing of HeLa Cancer Cells Using Facile Synthesized Pure and Ag Loaded WO 3 Nanoparticles.

Scientific Reports 2018 October 16
Chemotherapy, the most commonly used therapeutic method for cancer, has the inherent constraint of low bioavailability. A number of physical cancer therapeutic treatments like radiation, ultrasound, photo-acoustic/photo thermal, microwave therapies are based on locating the afflicted sites with the help of imaging, but the serious drawbacks of these treatment options are that they damage the neighboring normal tissues and/or induce undesired cancer metastasis. In addition, these methods of treatment are very expensive and not in the reach of a common man especially in the developing countries. Therefore, innovative, less invasive and cost effective treatment methods with the help of less toxic drugs have been sought for treating cancer. In this work, photo-catalytic method of killing cancer cells, using the nanostructured silver loaded tungsten oxide (Ag/WO3 ) as photo-catalysts, in conjunction with broadband UV radiation is presented. Ag/WO3 with two different mass ratios of Ag and WO3 (1% Ag/WO3 and 3% Ag/WO3 ) were synthesized, characterized and these nanostructured materials served as photo-catalysts in the process of killing cancer cells by photo-catalytic method. The advantage of loading Ag in WO3 is quite evident from the observed increase in the photo-catalytic killing of the HeLa cells. This photo-catalytic enhancement was effectively caused by the development of Schottky junction between Ag in WO3 , which led to a substantial inhibition of photo-generated charge recombination and also by the stimulation of surface plasmon resonance in silver nanoparticles, which led to the enhanced visible light absorption by the material.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app